Adocia, Inc. announced the launch of a Phase I clinical study in collaboration with Dr. Ahmad Haidar, McGill University, Canada, to assess pharmacokinetic, glycemic control and safety of BioChaperone® Lispro Pramlintide prandial formulation in 16 people with type I diabetes compared to rapid insulin lispro.
[Adocia, Inc.]